96 related articles for article (PubMed ID: 11717174)
1. Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.
Kim JY; Baek M; Lee S; Kim SO; Dong MS; Kim BR; Kim DH
Drug Metab Dispos; 2001 Dec; 29(12):1555-60. PubMed ID: 11717174
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved.
Baek MS; Kim JY; Myung SW; Yim YH; Jeong JH; Kim DH
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):381-8. PubMed ID: 11259320
[TBL] [Abstract][Full Text] [Related]
3. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
Franklin MR; Hathaway LB
Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components.
Chatterjee P; Franklin MR
Drug Metab Dispos; 2003 Nov; 31(11):1391-7. PubMed ID: 14570772
[TBL] [Abstract][Full Text] [Related]
5. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity.
Pearce RE; McIntyre CJ; Madan A; Sanzgiri U; Draper AJ; Bullock PL; Cook DC; Burton LA; Latham J; Nevins C; Parkinson A
Arch Biochem Biophys; 1996 Jul; 331(2):145-69. PubMed ID: 8660694
[TBL] [Abstract][Full Text] [Related]
6. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
Murray M; Butler AM; Stupans I
J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
[TBL] [Abstract][Full Text] [Related]
7. Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.
Voorman RL; Maio SM; Payne NA; Zhao Z; Koeplinger KA; Wang X
J Pharmacol Exp Ther; 1998 Oct; 287(1):381-8. PubMed ID: 9765359
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
10. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
[TBL] [Abstract][Full Text] [Related]
11. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.
Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T
Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate.
Lillibridge JH; Liang BH; Kerr BM; Webber S; Quart B; Shetty BV; Lee CA
Drug Metab Dispos; 1998 Jul; 26(7):609-16. PubMed ID: 9660842
[TBL] [Abstract][Full Text] [Related]
13. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
Tang C; Shou M; Rodrigues AD
Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
Li J; Liu Y; Zhang JW; Wei H; Yang L
Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide.
Pekthong D; Martin H; Abadie C; Bonet A; Heyd B; Mantion G; Richert L
J Ethnopharmacol; 2008 Feb; 115(3):432-40. PubMed ID: 18053665
[TBL] [Abstract][Full Text] [Related]
16. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
Tang J; Amin Usmani K; Hodgson E; Rose RL
Chem Biol Interact; 2004 Apr; 147(3):319-29. PubMed ID: 15135087
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors.
Monostory K; Hazai E; Vereczkey L
Chem Biol Interact; 2004 Apr; 147(3):331-40. PubMed ID: 15135088
[TBL] [Abstract][Full Text] [Related]
19. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.
Nakajima M; Yoshida R; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2001 Aug; 29(8):1110-3. PubMed ID: 11454729
[TBL] [Abstract][Full Text] [Related]
20. Properties and regional expression of a CYP3A-like protein in channel catfish intestine.
James MO; Lou Z; Rowland-Faux L; Celander MC
Aquat Toxicol; 2005 May; 72(4):361-71. PubMed ID: 15848255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
